Shanghai GenTech Co., Ltd. (SHA:688596)
China · Delayed Price · Currency is CNY 33.34
-0.05 (-0.15%)
May 8, 2026, 3:00 PM CST
Shanghai GenTech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,208 | 4,915 | 5,468 | 3,835 | 2,705 | 1,836 |
Other Revenue | 1.56 | 1.56 | 0.96 | 0.17 | 0.21 | 0.43 |
| 5,210 | 4,916 | 5,469 | 3,835 | 2,705 | 1,837 | |
Revenue Growth (YoY) | -6.25% | -10.11% | 42.63% | 41.78% | 47.26% | 65.63% |
Cost of Revenue | 4,206 | 3,910 | 4,065 | 2,810 | 1,972 | 1,363 |
Gross Profit | 1,004 | 1,006 | 1,404 | 1,024 | 732.46 | 473.72 |
Selling, General & Admin | 458.34 | 438.35 | 398.79 | 338.34 | 311.36 | 219.8 |
Research & Development | 320.19 | 328.39 | 349.28 | 251.02 | 149.91 | 78.22 |
Other Operating Expenses | 7.04 | 1.41 | -3.48 | -11.02 | 11.19 | 11.02 |
Operating Expenses | 890.95 | 864.24 | 825.96 | 644.13 | 504.73 | 327.36 |
Operating Income | 113.34 | 141.88 | 578.23 | 380.15 | 227.73 | 146.36 |
Interest Expense | -98.91 | -84.9 | -31.51 | -25.93 | -18.25 | -3.68 |
Interest & Investment Income | 11.18 | 13.27 | 10.46 | 22.92 | 14.07 | 10.18 |
Currency Exchange Gain (Loss) | -9.5 | -9.5 | -2.1 | -4.77 | -0.66 | -0.24 |
Other Non Operating Income (Expenses) | -5.57 | -2.73 | -0.5 | -4.08 | -2.77 | -1.71 |
EBT Excluding Unusual Items | 10.54 | 58.02 | 554.58 | 368.29 | 220.12 | 150.92 |
Gain (Loss) on Sale of Investments | -25.5 | -30.17 | -24.44 | 53.68 | 25.7 | 16.29 |
Gain (Loss) on Sale of Assets | 0.74 | 0.38 | -4.44 | 0.01 | -0.01 | 0.11 |
Asset Writedown | -2.99 | - | - | - | - | - |
Other Unusual Items | 69.95 | 69.95 | 63.93 | 18.55 | 22.19 | 16.02 |
Pretax Income | 52.75 | 98.18 | 589.62 | 440.53 | 268 | 183.34 |
Income Tax Expense | -25.08 | -40.47 | 20.8 | 17.14 | 6.73 | 15.21 |
Earnings From Continuing Operations | 77.82 | 138.65 | 568.82 | 423.39 | 261.27 | 168.13 |
Minority Interest in Earnings | -1.54 | -2.35 | -41.08 | -22.05 | -2.51 | 0.27 |
Net Income | 76.28 | 136.3 | 527.75 | 401.34 | 258.77 | 168.4 |
Net Income to Common | 76.28 | 136.3 | 527.75 | 401.34 | 258.77 | 168.4 |
Net Income Growth | -85.80% | -74.17% | 31.50% | 55.10% | 53.66% | 35.53% |
Shares Outstanding (Basic) | 283 | 284 | 281 | 273 | 256 | 255 |
Shares Outstanding (Diluted) | 283 | 284 | 284 | 281 | 264 | 259 |
Shares Change (YoY) | -1.02% | 0.08% | 1.10% | 6.29% | 1.92% | 20.93% |
EPS (Basic) | 0.27 | 0.48 | 1.88 | 1.47 | 1.01 | 0.66 |
EPS (Diluted) | 0.27 | 0.48 | 1.86 | 1.43 | 0.98 | 0.65 |
EPS Growth | -85.66% | -74.19% | 30.07% | 45.92% | 50.77% | 12.07% |
Free Cash Flow | -171.05 | -169.16 | -25.23 | -244.64 | -421.95 | -206.8 |
Free Cash Flow Per Share | -0.60 | -0.60 | -0.09 | -0.87 | -1.60 | -0.80 |
Dividend Per Share | 0.100 | 0.100 | 0.280 | 0.286 | - | 0.134 |
Dividend Growth | -64.23% | -64.23% | -2.41% | - | - | 34.28% |
Gross Margin | 19.28% | 20.46% | 25.67% | 26.71% | 27.08% | 25.79% |
Operating Margin | 2.18% | 2.89% | 10.57% | 9.91% | 8.42% | 7.97% |
Profit Margin | 1.46% | 2.77% | 9.65% | 10.47% | 9.57% | 9.17% |
Free Cash Flow Margin | -3.28% | -3.44% | -0.46% | -6.38% | -15.60% | -11.26% |
EBITDA | 286.1 | 298.28 | 669.26 | 440.38 | 270.4 | 181.03 |
EBITDA Margin | 5.49% | 6.07% | 12.24% | 11.48% | 10.00% | 9.86% |
D&A For EBITDA | 172.75 | 156.41 | 91.03 | 60.23 | 42.67 | 34.66 |
EBIT | 113.34 | 141.88 | 578.23 | 380.15 | 227.73 | 146.36 |
EBIT Margin | 2.18% | 2.89% | 10.57% | 9.91% | 8.42% | 7.97% |
Effective Tax Rate | - | - | 3.53% | 3.89% | 2.51% | 8.30% |
Revenue as Reported | 5,210 | 4,916 | 5,469 | 3,835 | 2,705 | 1,837 |
Advertising Expenses | - | 5.26 | 6.31 | 3.11 | 0.53 | 2.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.